NCT00958308View on ClinicalTrials.gov

Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions
Antibiotic-Associated DiarrheaClostridium Difficile-Associated Diarrhea
Interventions
OTHER

BIO-K+ CL-1285®

A mixture of Lactobacillus acidophilus and Lactobacillus casei, contains over 50 billion living bacteria per administered dose.

OTHER

Placebo

Placebo is devoid of microorganisms.

Sponsors
All Listed Sponsors
collaborator

Sprim Advanced Life Sciences

OTHER

lead

Bio-K Plus International Inc.

INDUSTRY